Federal Register / Vol. 89, No. 227 / Monday, November 25, 2024 / Notices 92947 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Initial 

Review Group; Epidemiology, Prevention 

and Behavior Research Study Section. 

Date: February 25, 2025. 

Time: 10:00 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institute of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700B Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Anna Ghambaryan, M.D., 

Ph.D., Scientific Review Officer, Extramural 

Project Review Branch, Office of Extramural 

Activities, 6700B Rockledge Drive, Room 

2120, MSC 6902, National Institute on 

Alcohol Abuse and Alcoholism, Bethesda, 

MD 20892, Tel: 301–443–4032, Email: 

anna.ghambaryan@nih.gov. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Initial 

Review Group; Neuroscience and Behavior 

Study Section. 

Date: March 4, 2025. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institute of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700B Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Beata Buzas, Ph.D., 

Scientific Review Officer, Extramural Project 

Review Branch, Office of Extramural 

Activities, 6700B Rockledge Drive, Room 

2116, MSC 6902, National Institute on 

Alcohol Abuse and Alcoholism, Bethesda, 

MD 20892, Tel: 301–443–0800, Email: 

bbuzas@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.273, Alcohol Research 

Programs, National Institutes of Health, HHS) 

Dated: November 19, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–27534 Filed 11–22–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of 

Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of 

meetings of the National Advisory 

Allergy and Infectious Diseases Council. 

The meetings will be held as virtual 

meetings and will be open to the public 

as indicated below. Individuals who 

plan to view the virtual meetings and 

need special assistance or other 

reasonable accommodations to view the 

meetings should notify the Contact 

Person listed below in advance of the 

meetings. The meetings can be accessed 

from the NIH Videocast at the following 

link: https://videocast.nih.gov/. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council. 

Date: January 27, 2025. 

Open: 10:30 a.m. to 11:30 a.m. 

Agenda: Report of Institute Director. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Closed: 11:45 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Kelly Y. Poe, Ph.D., 

Director, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 4F50, Bethesda, MD 

20892, 301–496–7291, poeky@mail.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council 

Allergy, Immunology and Transplantation 

Subcommittee. 

Date: January 27, 2025. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Open: 1:00 p.m. to 4:00 p.m. 

Agenda: Report of the Division Director 

and Division Staff. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Kelly Y. Poe, Ph.D., 

Director, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 4F50, Bethesda, MD 

20892, 301–496–7291, poeky@mail.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council 

Microbiology and Infectious Diseases 

Subcommittee. 

Date: January 27, 2025. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Open: 1:00 p.m. to 4:00 p.m. 

Agenda: Report of the Division Director 

and Division Staff. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Kelly Y. Poe, Ph.D., 

Director, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 4F50, Bethesda, MD 

20892, 301–496–7291, poeky@mail.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council 

Acquired Immunodeficiency Syndrome 

Subcommittee. 

Date: January 27, 2025. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Open: 1:00 p.m. to 4:00 p.m. 

Agenda: Report of Division Director and 

Division Staff. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 4F30, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Kelly Y. Poe, Ph.D., 

Director, Division of Extramural Activities, 

National Institute of Allergy and Infectious, 

Diseases National Institutes of Health, 5601 

Fishers Lane, Room 4F50, Bethesda, MD 

20892, 301–496–7291, poeky@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice at least 10 days in advance of the 

meeting. The statement should include the 


khammond on DSK9W7S144PROD with NOTICES
92948 Federal Register / Vol. 89, No. 227 / Monday, November 25, 2024 / Notices 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: https://

www.niaid.nih.gov/about/advisory-council, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: November 19, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–27485 Filed 11–22–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; NIDDK RC2 

Application Review. 

Date: February 13, 2025. 

Time: 12:00 p.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

NIDDK, Democracy II, Suite 7000A, 6707 

Democracy Boulevard, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Cheryl Nordstrom, Ph.D., 

MPH, Scientific Review Officer, NIDDK/ 

Scientific Review Branch, National Institutes 

of Health, 6707 Democracy Blvd., Room 

7013, Bethesda, MD 20892, 301–402–6711, 

cheryl.nordstrom@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: November 19, 2024 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–27536 Filed 11–22–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Docket ID FEMA–2024–0002] 

Final Flood Hazard Determinations 

AGENCY: Federal Emergency 

Management Agency, Department of 

Homeland Security. 

ACTION: Notice. 

SUMMARY: Flood hazard determinations, 

which may include additions or 

modifications of Base Flood Elevations 

(BFEs), base flood depths, Special Flood 

Hazard Area (SFHA) boundaries or zone 

designations, or regulatory floodways on 

the Flood Insurance Rate Maps (FIRMs) 

and where applicable, in the supporting 

Flood Insurance Study (FIS) reports 

have been made final for the 

communities listed in the table below. 

The FIRM and FIS report are the basis 

of the floodplain management measures 

that a community is required either to 

adopt or to show evidence of having in 

effect in order to qualify or remain 

qualified for participation in the Federal 

Emergency Management Agency’s 

(FEMA’s) National Flood Insurance 

Program (NFIP). 

DATES: The date of February 28, 2025 

has been established for the FIRM and, 

where applicable, the supporting FIS 

report showing the new or modified 

flood hazard information for each 

community. 

ADDRESSES: The FIRM, and if 

applicable, the FIS report containing the 

final flood hazard information for each 

community is available for inspection at 

the respective Community Map 

Repository address listed in the tables 

below and will be available online 

through the FEMA Map Service Center 

at https://msc.fema.gov by the date 

indicated above. 

FOR FURTHER INFORMATION CONTACT: Rick 

Sacbibit, Chief, Engineering Services 

Branch, Federal Insurance and 

Mitigation Administration, FEMA, 400 

C Street SW, Washington, DC 20472, 

(202) 646–7659, or (email) 

patrick.sacbibit@fema.dhs.gov; or visit 

the FEMA Mapping and Insurance 

eXchange (FMIX) online at https://

www.floodmaps.fema.gov/fhm/fmx_

main.html. 

SUPPLEMENTARY INFORMATION: The 

Federal Emergency Management Agency 

(FEMA) makes the final determinations 

listed below for the new or modified 

flood hazard information for each 

community listed. Notification of these 

changes has been published in 

newspapers of local circulation and 90 

days have elapsed since that 

publication. The Deputy Associate 

Administrator for Insurance and 

Mitigation has resolved any appeals 

resulting from this notification. 

This final notice is issued in 

accordance with section 110 of the 

Flood Disaster Protection Act of 1973, 

42 U.S.C. 4104, and 44 CFR part 67. 

FEMA has developed criteria for 

floodplain management in floodprone 

areas in accordance with 44 CFR part 

60. 

Interested lessees and owners of real 

property are encouraged to review the 

new or revised FIRM and FIS report 

available at the address cited below for 

each community or online through the 

FEMA Map Service Center at https://

msc.fema.gov. 

The flood hazard determinations are 

made final in the watersheds and/or 

communities listed in the table below. 

(Catalog of Federal Domestic Assistance No. 

97.022, ‘‘Flood Insurance.’’) 

Nicholas A. Shufro, 

Assistant Administrator (Acting) for Risk 

Management, Federal Emergency 

Management Agency, Department of 

Homeland Security. 

Community Community map repository address 

Kenai Peninsula Borough, Alaska and Incorporated Areas 

Docket No.: FEMA–B–2351 

City of Kenai ............................................................................................. City Hall, 210 Fidalgo Avenue, Kenai, AK 99611. 

City of Soldotna ........................................................................................ City Hall, 177 North Birch Street, Soldotna, AK 99669. 


khammond on DSK9W7S144PROD with NOTICES